IDOX PLC
06 February 2007
IDOX plc
6th February 2007
IDOX plc
('IDOX' or the 'Company')
Grant of options and directors' interests
IDOX announces that yesterday, options were granted to the below-noted directors
following the agreement of the terms of these options at the Board meeting on
7th December 2006. All options referred to are exercisable over ordinary shares
of 1p each in the capital of the Company ('Ordinary Shares') and were granted
under the terms of the IDOX plc EMI scheme ('EMI Scheme') and IDOX plc Share
Option Plan ('Option Plan').
Director No. of options granted
Martin Brooks, Chairman and Chief Executive Officer 4,500,000
Richard Kellett-Clarke, Finance Director 4,500,000
In the case of Martin Brooks, the options must be exercised within 12 months of
ceasing to be CEO, if he remains on the Board or, if earlier, within 3 months of
ceasing to be an employee of the Company.
In the case of Richard Kellett-Clarke, the options must be exercised within 12
months of ceasing to be an Executive Director if he remains on the Board or, if
earlier, within 3 months of ceasing to be an employee of the Company.
The options to each individual were awarded in two tranches subject to the
following conditions:
# of options Exercise Vesting Latest exercise
price/p date
Tranche 1
EMI Scheme 1,538,461 6.5 When granted 31 October 2011
Option Plan 711,539 6.5 When granted 31 October 2011
Tranche 2
Option Plan 2,250,000 9.0 Quarterly over
3 yrs 31 October 2014
In addition to the share options above, Martin Brooks and Richard Kellett-Clarke
hold the following interests in the share capital of the Company:
Director Nature of Ordinary shares % of current
Holding held issued share
capital
Martin Brooks Direct 186,046 0.09
Indirect 586,794 0.31
Total 772,840 0.40
Richard Kellett-Clarke Direct 600,000 0.31
For further information please contact:
Martin Brooks, Chairman and CEO, IDOX plc Tel: +44 (0)870 333 7101
John McNicol, Company Secretary, IDOX plc Tel: +44 (0)141 574 1935
Matthew Hall, Noble & Company Ltd Tel: +44 (0)20 7763 2200
This information is provided by RNS
The company news service from the London Stock Exchange IEIID
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.